Skip to main content
SpringerLink
Log in

A study of serum CASA and CA 125 levels in patients with ovarian carcinoma

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

The assays of Cancer Associated Serum Antigen (CASA) and CA 125 were assessed in the management of patients with ovarian cancer. It was shown that CASA is sensitive to ovarian carcinoma, and both CASA and CA 125 are more useful when used in conjunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Devine PL, McGuckin MA, Ward BG (1992) Circulating mucins as tumor markers in ovarian cancer. Anticancer Res 12:709–717

    Google Scholar 

  • Fioretti P, Gadducci A, Ferdeghini M, Prontera C, Malagnino G, Facchini V, Mariani G, Bianchi R (1992) The concomitant determination of different serum tumor markers in epithelial ovarian relevance for monitoring the response to chemotherapy and follow-up of patients. Gynecol Oncol 44:155–160

    Google Scholar 

  • Kreienberg R (1989) Immundiagnostik und ihre Relevanz bei Tumorerkrankungen, Immuntherapie bei Tumorerkrankungen. Gynäkologe 23:122–129

    Google Scholar 

  • McGuckin MA, Layton GT, Bailey MJ, Hurst T, Khoo SK, Ward BG (1990) Evaluation of two new assays for tumour associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma: comparison with CA 125. Gynecol Oncol 37:165–171

    Google Scholar 

  • Ward BG (1992) Serum assays in the management of ovarian carcinoma. Int J Gynecol Cancer 1:10–18

    Google Scholar 

  • Ward BG, McGuckin MA, Ramm L, Forbes KL (1991) Expression of tumour markers CA 125, CASA and OSA in minimal/mild endometriosis. Aust NZ Obstet Gynaecol 31:273–275

    Google Scholar 

  • Ward BG, McGuckin MA, Ramm LE, Coglan M, Tripcony L, Free KE (1993) The management of ovarian carcinoma is improved by use of cancer-associated serum antigen and CA 125 assays. Cancer 71:430–438

    Google Scholar 

  • Zotter S, Hageman PC, Lossnitzer A, Moo WJ, Hilgers J (1988) Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Res 11-12:55–101

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Ernst Moritz Arndt University, Wollweberstraße 1, D-17487, Greifswald, Germany

    M. Meisel, W. Straube, J. Weise & B. Burkhardt

Authors
  1. M. Meisel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Straube
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Weise
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Burkhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meisel, M., Straube, W., Weise, J. et al. A study of serum CASA and CA 125 levels in patients with ovarian carcinoma. Arch Gynecol Obstet 256, 9–15 (1995). https://doi.org/10.1007/BF00634342

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00634342

Key words

Search

Navigation